Epidemiology from Literature | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | 1.5 - Atopic Dermatitis, Diagnosed | 2014 | Netherlands | IgE | 211 | 53.100 | 20140331, Rockmann H
| 3.2.1 - Source Sensitized (IgE) | 2014 | France | IgE | 68 | 33.000 | 20141107, Agabriel C
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2014 | France | IgE | 68 | 25.000 | 20141107, Agabriel C
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2014 | Japan | IgE | 16 | 0.000 | 20140623, Nozawa A
| 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 2013 | Sweden / USA | IgE | 167 | 43.100 | 20130113, Lieberman JA
| 1.3 - Rhinitis, Diagnosed | 2013 | Brazil | IgE | 101 | 0.000 | 20130912, Lacerda Araujo LM
| 1.11 - Esophagitis, Diagnosed | 2013 | Netherlands | IgE | 76 | 21.100 | 20131020, van Rhijn BD
| 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 2013 | Italy | IgE | 48 | 35.000 | 20131128, Calamelli E
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2013 | Netherlands | IgE | 42 | 54.760 | 20130429, Aalberse JA
| 5.1.1 - Source Exposed (Symptoms) | 2013 | Netherlands | IgE | 37 | 62.160 | 20130428, Klemans RJ
| 1.11 - Esophagitis, Diagnosed | 2013 | Switzerland | IgE | 35 | 17.140 | 20130605, Simon D
| 3.2.1 - Source Sensitized (IgE) | 2013 | Italy | IgE | 24 | 33.000 | 20131128, Calamelli E
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2013 | Italy | IgE | 24 | 37.000 | 20131128, Calamelli E
| 3.1.4 - Source Sensitized (SPT, IgE) | 2013 | Netherlands | IgE | 22 | 63.640 | 20130429, Aalberse JA
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2013 | Austria | IgE | 20 | 95.000 | 20130401, Berneder M
| 3.2.1 - Source Sensitized (IgE) | 2013 | Slovenia | IgE | 16 | 43.750 | 20131106, Homsak M
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2013 | Slovenia | IgE | 11 | 36.360 | 20131106, Homsak M
| 6.2 - General Population (Adults) | 2012 | Sweden | IgE | 371 | 3.500 | 20120528, Patelis A
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 51.120 | 20110223, De Knop KJ
| 1.2.1 - Asthma, Diagnosed (Adults) | 2012 | Sweden | IgE | 96 | 14.580 | 20120528, Patelis A
| 3.1.1 - Source Sensitized (SPT) | 2012 | Spain | IgE | 79 | 11.390 | 20121016, Javaloyes G
| 3.1.4 - Source Sensitized (SPT, IgE) | 2012 | Spain | IgE | 68 | 2.900 | 20120726, Pedrosa M
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2012 | Spain | IgE | 55 | 7.300 | 20120726, Pedrosa M
| 5.3.2 - Source Exposed (Symptoms, high IgE) | 2012 | Taiwan | IgE | 29 | 13.800 | 20120319, Lin YT
| 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 0.000 | 20110223, De Knop KJ
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2011 | Sweden | IgE | 74 | 70.270 | 20110701, Moverare R
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2011 | Netherlands | IgE | 12 | 41.670 | 20110304, Vissers YM
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2011 | Netherlands | IgE | 8 | 100.000 | 20110304, Vissers YM
| 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 2010 | France | IgE | 166 | 39.760 | 20100923, Codrenau F
| 3.2.1 - Source Sensitized (IgE) | 2010 | Sweden | IgE | 100 | 19.000 | 20100212, Asarnoj A
| 1.10 - Any allergy symptom, Diagnosed | 2010 | Belgium | IgE | 86 | 17.440 | 20101214, Gadisseur R
| 1.10 - Any allergy symptom, Diagnosed | 2010 | France | IgE | 61 | 68.850 | 20100923, Codrenau F
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2010 | Spain | IgE | 50 | 2.000 | 20101124, Vereda A
| 4.1.5 - Heterologous Source Sensitized (IgE) | 2010 | Sweden | IgE | 50 | 22.000 | 20100212, Asarnoj A
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2010 | Sweden | IgE | 35 | 65.700 | 20101124, Vereda A
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2010 | United States | IgE | 30 | 19.100 | 20101124, Vereda A
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 64.860 | 20090826, Ebo DG
| 10.1 - Normal Control | 2009 | Belgium | IgE | 26 | 0.000 | 20091121, Ebo DG
| 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 18.180 | 20091121, Ebo DG
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Italy | IgE | 21 | 0.000 | 20090808, Krause S
| 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Belgium | IgE | 20 | 60.000 | 20091121, Ebo DG
| 1.5 - Atopic Dermatitis, Diagnosed | 2009 | Germany | IgE | 20 | 50.000 | 20091005, Ott H
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2004 | Netherlands / Switzerland | IgE | 20 | 85.000 | 20041204, Mittag D
|
|